Andy King - July 10, 2025

SkyKick Fallout: UKIPO Tightens Rules on Broad Trade Mark Specs

Following the Supreme Court’s decision in SkyKick UK Ltd v Sky Ltd [2024] UKSC 36, the UKIPO has ...

Andrew Pitts - July 10, 2025

G 1/23 – Redefining when a product can be state of the art

The Enlarged Board of Appeal (EBA) at the EPO recently handed down the long-expected decision G ...

Katherine Green - July 9, 2025

Most opposed companies at the EPO in 2024

Opposition activity at the European Patent Office is often a strong indicator of a technology’s ...

Emily Lloyd - July 8, 2025

AI agents – future colleagues?

The onset of AI tools is leading to drastic changes in the workplace with more and more companies ...

Rebecca Blundell - July 7, 2025

Resilient Chemistry – a conversation with Professor Peter Licence

Peter Licence explains how resilient chemistry can ensure the long-term viability of the chemical ...

Matthew Naylor - July 7, 2025

UPC Weekly - Extra time, suspensions and replays. Part II – suspensive effect

2025 Week 27 Last week, we looked at how the UPC deals with requests for extensions of time. This ...

Adam Gregory - July 4, 2025

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

Mewburn Ellis works with some of the world’s most important pharmaceuticals and biologics across a ...

Luke Jones - July 2, 2025

AI’s Powerhouse: The Hardware Behind the Intelligence

As AI models grow ever larger and more powerful, the conversation often focuses on new model ...